Is there a role for new oral anticoagulants as primary and secondary stroke prevention in atrial fibrillation and intracranial stenosis?
Autor: | Josef Finsterer, Adam Bastovansky, Claudia Stöllberger |
---|---|
Rok vydání: | 2013 |
Předmět: |
medicine.medical_specialty
Stroke patient business.industry Intracranial stenosis Ischemic strokes medicine.medical_treatment Atrial fibrillation Hematology medicine.disease Cerebral atherosclerosis Stroke prevention Internal medicine Cardiology Medicine In patient Cardiac monitoring Cardiology and Cardiovascular Medicine business |
Zdroj: | Journal of Thrombosis and Thrombolysis. 36:492-494 |
ISSN: | 1573-742X 0929-5305 |
DOI: | 10.1007/s11239-013-0884-1 |
Popis: | Ischemic strokes in patients with atrial fibrillation (AF) are due to a variety of mechanisms, and are not necessarily the result of cardiogenic embolism. Due to improvement in imaging technology the detection of extraand intracranial stenoses is noninvasively possible, and improvements of cardiac monitoring devices have increased the detection rate of previously unknown AF in stroke patients [1]. The coincidence of AF and cerebral atherosclerosis leads to therapeutic considerations as illustrated by the following example. |
Databáze: | OpenAIRE |
Externí odkaz: |